{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:54:29Z","timestamp":1787014469637,"version":"build-2736575974"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Background Filaggrin is a key protein involved in maintaining skin barrier function and hydration. Mutations in the filaggrin gene (FLG) cause ichthyosis vulgaris (IV) and are a major predisposing factor for atopic dermatitis (AD) in individuals of European and Asian descent. It has been proposed that FLG mutations are population specific and a difference in the spectra of mutations between different ancestral groups has been described. However, it is unknown whether FLG mutations in the African population are a causative genetic factor for IV and predispose to AD, or whether other mechanisms are more prominent.<\/jats:p>\n                  <jats:p>Objectives The present aim was to investigate the role of FLG mutations as predisposing factors for IV or AD among individuals from Ethiopia.<\/jats:p>\n                  <jats:p>Methods A case series of Ethiopian patients with AD (n = 103) and IV (n = 7) together with controls (n = 103; subjects without past or present history of AD, dry skin or atopic manifestations) was collected at the outpatient dermatology clinics at ALERT Dermatology Hospital, Tikur Anbessa Hospital and Gondar University Hospital, Ethiopia. AD was diagnosed by a dermatologist using the U.K. Working Party\u2019s diagnostic criteria. The IV diagnosis was based on clinical examination and genetic testing of the steroid sulphatase gene to exclude X-linked recessive ichthyosis. Patients were studied with direct sequencing (n = 40) and\/or allelic discrimination (n = 110). Immunohistochemical analysis was performed for filaggrin expression in the skin of patients (n = 7) and controls (n = 2).<\/jats:p>\n                  <jats:p>Results The Ethiopian patients and controls were genotyped for the four previously described common European FLG null mutations (R501X, 2282del4, S3247X, R2447X) and no carriers were found. In one patient with AD a novel heterozygous 2-bp deletion, 632del2, leading to a premature stop codon was revealed by direct sequencing. No additional carrier of this deletion or other mutations was found. In addition, no difference in filaggrin expression was detected in AD or IV skin compared with healthy control skin.<\/jats:p>\n                  <jats:p>Conclusions Our results indicate that FLG loss-of-function-variants are less common in patients with IV and AD in the Ethiopian population, suggesting that other factors may be of importance in the pathogenesis in this ethnic group.<\/jats:p>","DOI":"10.1111\/j.1365-2133.2011.10475.x","type":"journal-article","created":{"date-parts":[[2011,6,21]],"date-time":"2011-06-21T08:35:41Z","timestamp":1308645341000},"page":"1074-1080","source":"Crossref","is-referenced-by-count":94,"title":["Novel filaggrin mutation but no other loss-of-function variants found in Ethiopian patients with atopic dermatitis"],"prefix":"10.1093","volume":"165","author":[{"given":"M.C.G.","family":"Winge","sequence":"first","affiliation":[{"name":"Dermatology Unit, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital Solna, SE-171 76 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.D.","family":"Bilcha","sequence":"additional","affiliation":[{"name":"Department of Dermatovenereology, Faculty of Medicine, Addis Ababa University, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lied\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine & Surgery and Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital Solna, SE-171 76 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Shibeshi","sequence":"additional","affiliation":[{"name":"Department of Dermatovenereology, Faculty of Medicine, Addis Ababa University, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sandilands","sequence":"additional","affiliation":[{"name":"Epithelial Genetics Group, Human Genetics Unit, Division of Pathology and Neuroscience, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 5EH, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-F.","family":"Wahlgren","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital Solna, SE-171 76 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.H.I.","family":"McLean","sequence":"additional","affiliation":[{"name":"Epithelial Genetics Group, Human Genetics Unit, Division of Pathology and Neuroscience, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 5EH, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nordenskj\u00f6ld","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine & Surgery and Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital Solna, SE-171 76 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bradley","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital Solna, SE-171 76 Stockholm, Sweden"},{"name":"Department of Molecular Medicine & Surgery and Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital Solna, SE-171 76 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,11,1]]},"reference":[{"key":"2023012703563231700_b1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(06)69283-0","article-title":"Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys","volume":"368","author":"Asher","year":"2006","journal-title":"Lancet"},{"key":"2023012703563231700_b2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/jid.2010.303","article-title":"Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process","volume":"131","author":"Schmitt","year":"2011","journal-title":"J Invest Dermatol"},{"key":"2023012703563231700_b3","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1365-2222.2004.1946.x","article-title":"Prevalence and associated factors of atopic dermatitis symptoms in rural and urban Ethiopia","volume":"34","author":"Yemaneberhan","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"2023012703563231700_b4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1398-9995.2007.01325.x","article-title":"Prevalence of symptoms of asthma, rhinitis and eczema in 13- to 14-year-old children in Africa: the International Study of Asthma and Allergies in Childhood Phase III","volume":"62","author":"Ait-Khaled","year":"2007","journal-title":"Allergy"},{"key":"2023012703563231700_b5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2133.1994.tb08532.x","article-title":"The U.K. Working Party\u2019s Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation","volume":"131","author":"Williams","year":"1994","journal-title":"Br J Dermatol"},{"key":"2023012703563231700_b6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0190-9622(93)70099-F","article-title":"Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample","volume":"28","author":"Schultz Larsen","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"2023012703563231700_b7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/86867","article-title":"Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci","volume":"27","author":"Cookson","year":"2001","journal-title":"Nat Genet"},{"key":"2023012703563231700_b8","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/hmg\/ddq019","article-title":"A milieu of regulatory elements in the epidermal differentiation complex syntenic block: implications for atopic dermatitis and psoriasis","volume":"19","author":"de Guzman Strong","year":"2010","journal-title":"Hum Mol Genet"},{"key":"2023012703563231700_b9","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/jid.2009.133","article-title":"Epidermal barrier dysfunction in atopic dermatitis","volume":"129","author":"Cork","year":"2009","journal-title":"J Invest Dermatol"},{"key":"2023012703563231700_b10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ng1743","article-title":"Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris","volume":"38","author":"Smith","year":"2006","journal-title":"Nat Genet"},{"key":"2023012703563231700_b11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/BF02505232","article-title":"Decreased expression of filaggrin in atopic skin","volume":"288","author":"Seguchi","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"2023012703563231700_b12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng1767","article-title":"Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis","volume":"38","author":"Palmer","year":"2006","journal-title":"Nat Genet"},{"key":"2023012703563231700_b13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2133.2009.09582.x","article-title":"FLG mutations in ichthyosis vulgaris and atopic eczema: spectrum of mutations and population genetics","volume":"162","author":"Akiyama","year":"2010","journal-title":"Br J Dermatol"},{"key":"2023012703563231700_b14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000245677","article-title":"Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis","volume":"195","author":"Kunz","year":"1997","journal-title":"Dermatology"},{"key":"2023012703563231700_b15","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1093\/nar\/gkf493","article-title":"Human non-synonymous SNPs: server and survey","volume":"30","author":"Ramensky","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"2023012703563231700_b16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jsbmb.2009.02.017","article-title":"Transcriptional control of human steroid sulfatase","volume":"115","author":"Nardi","year":"2009","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2023012703563231700_b17","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1038\/sj.jid.5700971","article-title":"Filaggrin mutations are genetic modifying factors exacerbating X-linked ichthyosis","volume":"127","author":"Liao","year":"2007","journal-title":"J Invest Dermatol"},{"key":"2023012703563231700_b18","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/ng2020","article-title":"Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema","volume":"39","author":"Sandilands","year":"2007","journal-title":"Nat Genet"},{"key":"2023012703563231700_b19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/jid.2008.413","article-title":"Eczema genetics: current state of knowledge and future goals","volume":"129","author":"Brown","year":"2009","journal-title":"J Invest Dermatol"},{"key":"2023012703563231700_b20","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/jid.2008.13","article-title":"Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery","volume":"128","author":"Jeong","year":"2008","journal-title":"J Invest Dermatol"},{"key":"2023012703563231700_b21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jaci.2004.10.024","article-title":"Early life risk factors for atopic dermatitis in Ethiopian children","volume":"115","author":"Haileamlak","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"2023012703563231700_b22","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1046\/j.1365-2222.2001.00987.x","article-title":"Atopy, intestinal helminth infection and total serum IgE in rural and urban adult Gambian communities","volume":"31","author":"Nyan","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"2023012703563231700_b23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2222.2008.03134.x","article-title":"Do helminth parasites protect against atopy and allergic disease?","volume":"39","author":"Flohr","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"2023012703563231700_b24","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/sj.jid.5700587","article-title":"Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood","volume":"127","author":"Barker","year":"2007","journal-title":"J Invest Dermatol"},{"key":"2023012703563231700_b25","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1398-9995.2010.02493.x","article-title":"Mutations in the filaggrin gene in Han Chinese patients with atopic dermatitis","volume":"66","author":"Zhang","year":"2011","journal-title":"Allergy"},{"key":"2023012703563231700_b26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2133.2010.09740.x","article-title":"Novel and recurrent mutations in the filaggrin gene in Chinese patients with ichthyosis vulgaris","volume":"163","author":"Zhang","year":"2010","journal-title":"Br J Dermatol"},{"key":"2023012703563231700_b27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jaci.2009.07.034","article-title":"Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum","volume":"124","author":"Gao","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"2023012703563231700_b28","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1126\/science.1124309","article-title":"Positive natural selection in the human lineage","volume":"312","author":"Sabeti","year":"2006","journal-title":"Science"},{"key":"2023012703563231700_b29","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/sj.jid.5700365","article-title":"Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis","volume":"126","author":"Irvine","year":"2006","journal-title":"J Invest Dermatol"},{"key":"2023012703563231700_b30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/35066048","article-title":"Phenotype\u2013genotype relationships in monogenic disease: lessons from the thalassaemias","volume":"2","author":"Weatherall","year":"2001","journal-title":"Nat Rev Genet"},{"key":"2023012703563231700_b31","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/371508a0","article-title":"Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria","volume":"371","author":"McGuire","year":"1994","journal-title":"Nature"},{"key":"2023012703563231700_b32","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/hmg\/6.8.1357","article-title":"A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya","volume":"6","author":"Fernandez-Reyes","year":"1997","journal-title":"Hum Mol Genet"},{"key":"2023012703563231700_b33","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0006-3002(55)90167-0","article-title":"Sun-screening effect of urocanic acid","volume":"18","author":"Zenisek","year":"1955","journal-title":"Biochim Biophys Acta"},{"key":"2023012703563231700_b34","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1038\/jid.2010.115","article-title":"Knockdown of filaggrin impairs diffusion barrier function and increases UV sensitivity in a human skin model","volume":"130","author":"Mildner","year":"2010","journal-title":"J Invest Dermatol"},{"key":"2023012703563231700_b35","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1365-2133.2009.09342.x","article-title":"Natural moisturizing factor components in the stratum corneum as biomarkers of filaggrin genotype: evaluation of minimally invasive methods","volume":"161","author":"Kezic","year":"2009","journal-title":"Br J Dermatol"},{"key":"2023012703563231700_b36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/jid.2010.277","article-title":"IL-25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction?","volume":"131","author":"Hvid","year":"2011","journal-title":"J Invest Dermatol"},{"key":"2023012703563231700_b37","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jaci.2008.01.013","article-title":"Filaggrin null mutations and childhood atopic eczema: a population-based case\u2013control study","volume":"121","author":"Brown","year":"2008","journal-title":"J Allergy Clin Immunol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2011.10475.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/165\/5\/1074\/47505652\/bjd1074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/165\/5\/1074\/47505652\/bjd1074.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T23:25:10Z","timestamp":1674775510000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/165\/5\/1074\/6643971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,1]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2011,11,1]]},"published-print":{"date-parts":[[2011,11,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10475.x","relation":{},"ISSN":["1365-2133","0007-0963"],"issn-type":[{"value":"1365-2133","type":"electronic"},{"value":"0007-0963","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,11,1]]},"published":{"date-parts":[[2011,11,1]]}}}